Venture Capital

Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and technology enabled business services industries. Our team brings over one hundred years of combined privat...
See More e equity experience to the investment process. Our broad experience, combined with expertise in finance; operations; engineering; life sciences research and development; partnering with pharmaceutical companies; business development; executive recruiting; and law provides significant value to the companies in which we invest. Since the early 1980's, members of our team have managed seven venture capital partnerships with successful results for our investors and our entrepreneurs.

Partners

A. Dana Callow, Jr.
Robert Sherman
Martin Hernon
Pat Fortune
Bruce Tiedemann

Investments and Funds

BMP has over $750 million under management among seven funds. The most recent fund was raised in 2011. Most companies are generating revenue at the time of our investment. Investments include Parexel (PRXL), GlycoFi (sold to Merck), Ilex (ILXO, acquired by Genzyme), Bright Horizons (BFAM), Verio Inc. (VRIO, acquired by NTT), Odyssey Logistics, Arthrosurface, and Athenix (sold to Bayer).

Follow us on Twitter @bostonmillennia